• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Chain Bridge I

    10/29/24 4:57:34 PM ET
    $CBRG
    Blank Checks
    Finance
    Get the next $CBRG alert in real time by email
    DEFA14A 1 tm2427066d2_defa14a.htm DEFA14A

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    SCHEDULE 14A INFORMATION

    Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

     

     

     

     

    Filed by the Registrant x

     

    Filed by a Party other than the Registrant ¨

     

    Check the appropriate box:

     

    ¨ Preliminary Proxy Statement

     

    ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

    ¨ Definitive Proxy Statement

     

    x Definitive Additional Materials

     

    ¨ Soliciting Material Pursuant to Section 240.14a-12

     

    CHAIN BRIDGE I

     

    (Name of Registrant as Specified in Its Charter)

     

     

     

     (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

     

    Payment of Filing Fee (Check all boxes that apply):

     

    x No fee required

     

    ¨ Fee paid previously with preliminary materials.

     

    ¨ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     

     

     

     

     

    CHAIN BRIDGE I

    8 The Green # 17538

    Dover, DE 19901

     

    PROXY STATEMENT

    AMENDMENT NO. 1

     

    On October 10, 2024, Chain Bridge I (the “Company”) filed its definitive proxy statement (the “Proxy Statement) with respect to its Extraordinary General Meeting scheduled for November 8, 2024.

     

    This Amendment No. 1 to the Proxy Statement is filed solely to disclose that on October 29, 2024, the Company and Fulton AC I LLC (the “CBRG Sponsor”) entered into an agreement pursuant to which the CBRG Sponsor agreed to reimburse the Trust Account (as defined in the Proxy Statement) up to $100,000 to pay dissolution expenses if and when the Company is dissolved. The amount of such reimbursements will be included in the amount distributable holders of Class A Ordinary Shares of the Company entitled to participate the liquidation of the Trust Account.

     

    Except as expressly noted above, this Amendment No. 1 does not modify or update in any way disclosures made in the Proxy Statement. Accordingly, this Amendment No. 1 should be read in conjunction with the Proxy Statement.

     

     

     

    Get the next $CBRG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CBRG

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CBRG
    SEC Filings

    See more
    • SEC Form 10-Q filed by Chain Bridge I

      10-Q - Chain Bridge I (0001845149) (Filer)

      11/19/24 5:29:41 PM ET
      $CBRG
      Blank Checks
      Finance
    • Chain Bridge I filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

      8-K - Chain Bridge I (0001845149) (Filer)

      11/19/24 6:05:29 AM ET
      $CBRG
      Blank Checks
      Finance
    • SEC Form NT 10-Q filed by Chain Bridge I

      NT 10-Q - Chain Bridge I (0001845149) (Filer)

      11/14/24 5:29:34 PM ET
      $CBRG
      Blank Checks
      Finance

    $CBRG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $CBRG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $CBRG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SEC Form 3 filed by new insider Kucharchuk Andrew Albert

      3 - Chain Bridge I (0001845149) (Issuer)

      4/5/24 4:19:27 PM ET
      $CBRG
      Blank Checks
      Finance
    • SEC Form 3 filed by new insider Wiener Oliver

      3 - Chain Bridge I (0001845149) (Issuer)

      2/22/24 4:13:59 PM ET
      $CBRG
      Blank Checks
      Finance
    • New insider Cb Co-Investment Llc claimed ownership of 575,665 units of Class A Ordinary Shares (SEC Form 3)

      3 - Chain Bridge I (0001845149) (Issuer)

      2/20/24 7:34:04 PM ET
      $CBRG
      Blank Checks
      Finance
    • Amendment: SEC Form SC 13G/A filed by Chain Bridge I

      SC 13G/A - Chain Bridge I (0001845149) (Subject)

      11/14/24 1:46:48 PM ET
      $CBRG
      Blank Checks
      Finance
    • Amendment: SEC Form SC 13G/A filed by Chain Bridge I

      SC 13G/A - Chain Bridge I (0001845149) (Subject)

      11/14/24 12:49:36 PM ET
      $CBRG
      Blank Checks
      Finance
    • Amendment: SEC Form SC 13G/A filed by Chain Bridge I

      SC 13G/A - Chain Bridge I (0001845149) (Subject)

      11/13/24 4:37:52 PM ET
      $CBRG
      Blank Checks
      Finance
    • Phytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth Potential

      NEW YORK and SANTA BARBARA, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Phytanix Bio, a pioneering preclinical stage pharmaceutical company dedicated to the development of therapeutics based on cannabinoid and cannabinoid-like molecules, today announced the release of its new investor deck. The updated presentation provides an in-depth look at the company's strategic vision, scientific advancements, and growth potential as it progresses towards the development of next-generation cannabinoid medicines. The global cannabis pharmaceuticals market size was estimated at USD 3.4 billion in 2023 and is anticipated to grow at a CAGR of 53.3% from 2024 to 2030. The investor deck is now available on

      7/30/24 9:00:00 AM ET
      $CBRG
      Blank Checks
      Finance
    • Chain Bridge I to Acquire Phytanix Bio, Creating a New Public Company Focused on Developing Next Generation Cannabinoid and Cannabinoid-like Medicines

      Phytanix Bio is a preclinical stage pharmaceutical company founded by former members and associates of GW Pharmaceuticals, holding exclusive cannabinoid and cannabinoid-like medicine intellectual property (IP)The transaction reflects a pre-deal valuation of $58 million for Phytanix Bio plus the assumption of $17 million of preferred stock and $4.4 million of short-term debt that will be exchanged for convertible preferred stock at deal closeThe business combination is expected to be completed in the fourth quarter of 2024, with the combined company to be listed on Nasdaq Capital Markets under the ticker "PHYX" NEW YORK and SANTA BARBARA, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Phytani

      7/22/24 5:45:34 PM ET
      $CBRG
      Blank Checks
      Finance
    • Chain Bridge I Will Redeem Public Shares

      Chain Bridge I (the "Company") (NASDAQ:CBRGU, CBRG, CBRGW))), a special purpose acquisition company, today announced that it will redeem all of its outstanding Class A ordinary shares, par value $0.0001 (the "Public Shares"), effective as of the close of business on November 15, 2023, as the Company will not consummate an initial business combination within the time period required by its Amended and Restated Memorandum and Articles of Association (the "Articles"). The Company concluded it would be unable to meet its expectations for quality and long-term return potential by completing an initial business combination by November 15, 2023 (twenty-four months from the closing of the Company

      10/31/23 4:00:00 PM ET
      $CBRG
      Blank Checks
      Finance